Table 3 Comparison between patients with atrial fibrosis and those without atrial fibrosis
From: The use of MRI in quantification of the atrial fibrosis in patients with rheumatic mitral disease
| Â | Patients with atrial fibrosis (n = 40) | Patients without atrial fibrosis (n = 20) | P value |
|---|---|---|---|
Age, year | 34.72 ± 8.11 | 28.40 ± 7.00 | 0.004 |
Gender, male | 19 (54.5%) | 3 (45.5%) | 0.014 |
DM | 5 (12.5%) | 0 | 0.159 |
HTN | 2 (5%) | 0 | 0.548 |
CVS | 1 (2.5%) | 0 | 0.99 |
Duration of symptoms, month | 29.55 ± 14.90 | 18.60 ± 7.76 | 0.003 |
Mitral valve area by echo, cm2 | 1.18 ± 0.162 | 1.38 ± 0.116 | < 0.001 |
LA diameter by echo, cm | 4.99 ± 0.537 | 4.46 ± 0.176 | < 0.001 |
LA diameter/BSA, cm/m2 | 2.71 ± 0.315 | 2.40 ± 0.184 | < 0.001 |
LA volume by echo, ml | 75.60 ± 7.45 | 67.90 ± 5.45 | < 0.001 |
LA volume index by echo, ml/m2 | 41.09 ± 4.37 | 37.07 ± 4.04 | 0.001 |
Atrial fibrillation | 30 (75%) | 0 | < 0.001 |